Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.

BMC Psychiatry · 2007 · PMC2020469 · PMID 17705840

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

Two active controlled trials (487 patients) had slightly lower relapse rates with olanzapine (32%) than lithium or divalproex (41%) but the difference was barely significant with a relative risk of 0.8 (0.6 to 0.98).

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.